Head and Neck Cancersfind mydrugscancerA Phase I Trial of 96-Hour Paclitaxel Infusion Plus Accelerated Radiotherapy for Unresectable Head and Neck CancerThe Impact of Nutritional Status on the Prognoses of Patients with Advanced Head and Neck CancerEvidence for a Causal Association Between Human Papillomavirus and a subset of Head and Neck CancersChemoradiotherapy versus Radiotherapy in Patients with Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099Simultaneous Radiochemotherapy versus Radiotherapy Alone in Advanced Head and Neck Cancer: a Randomized Multi-center StudyChemoradiotherapy Versus Radiotherapy in Patients With Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099Preradiotherapy Computed Tomography as a Predictor for Local Control in Supraglottic CarcinomaRecurrences after Conformal Parotid-Sparing RadiotherapyHyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerAn Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck CancerPhase III Study of Concurrent Chemoradiotherapy versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free SurvivalPostoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancerPostoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck, RTOG 9501/IntergroupInduction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
A Phase I Trial of 96-Hour Paclitaxel Infusion Plus Accelerated Radiotherapy for Unresectable Head and Neck Cancer
Chemoradiotherapy versus Radiotherapy in Patients with Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099
Simultaneous Radiochemotherapy versus Radiotherapy Alone in Advanced Head and Neck Cancer: a Randomized Multi-center Study
Chemoradiotherapy Versus Radiotherapy in Patients With Advanced Nasopharyngeal Cancer: Phase III Randomized Intergroup Study 0099
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
Phase III Study of Concurrent Chemoradiotherapy versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free Survival
Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck, RTOG 9501/Intergroup
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer